Subsets of human natural killer cells and their regulatory effects

Immunology

Volumn 141, Issue 4, 2014, Pages 483-489

  Fu, Binqing ^a,b   Tian, Zhigang ^a,b   Wei, Haiming ^a,b  

^a UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^b UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

Author keywords

Cell differentiation; Human natural killer cells

Indexed keywords

CD11B ANTIGEN; CD27 ANTIGEN; TRANSCRIPTION FACTOR GATA 3;

CELL DIFFERENTIATION; HUMAN; INFLAMMATION; MICROENVIRONMENT; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SMALL INTESTINE;

CELL DIFFERENTIATION; HUMAN NATURAL KILLER CELLS;

ANTIGENS, CD11B; ANTIGENS, CD27; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CYTOKINES; HOMEOSTASIS; HUMANS; IMMUNITY, INNATE; INFLAMMATION; INFLAMMATION MEDIATORS; KILLER CELLS, NATURAL; LYMPHOCYTE SUBSETS; PHENOTYPE;

EID: 84895797883     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/imm.12224     Document Type: Review

References (79)

1. Caligiuri MA. Human natural killer cells. Blood 2008; 112:461-9.
2. Flodstrom-Tullberg M, Bryceson YT, Shi FD, Hoglund P, Ljunggren HG. Natural killer cells in human autoimmunity. Curr Opin Immunol 2009; 21:634-40.
3. Narni-Mancinelli E, Ugolini S, Vivier E. Tuning the threshold of natural killer cell responses. Curr Opin Immunol 2013; 25:53-8.
4. Hayakawa Y, Smyth MJ. CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity. J Immunol 2006; 176:1517-24.
5. Vossen MT, Matmati M, Hertoghs KM et al. CD27 defines phenotypically and functionally different human NK cell subsets. J Immunol 2008; 180:3739-45.
6. Hayakawa Y, Huntington ND, Nutt SL, Smyth MJ. Functional subsets of mouse natural killer cells. Immunol Rev 2006; 214:47-55.
7. Chiossone L, Chaix J, Fuseri N, Roth C, Vivier E, Walzer T. Maturation of mouse NK cells is a 4-stage developmental program. Blood 2009; 113:5488-96.
8. Zhang C, Zhang J, Tian Z. The regulatory effect of natural killer cells: do "NK-reg cells" exist? Cell Mol Immunol 2006; 3:241-54.
9. Lanier LL, Le AM, Phillips JH, Warner NL, Babcock GF. Subpopulations of human natural-killer cells defined by expression of the Leu-7 (Hnk-1) and Leu-11 (Nk-15) antigens. J Immunol 1983; 131:1789-96.
10. Poli A, Michel T, Thérésine M, Andrès E, Hentges F, Zimmer J. CD56 (bright) natural killer (NK) cells: an important NK cell subset. Immunology 2009; 126:458-65.
11. Kim S, Iizuka K, Kang HS, Dokun A, French AR, Greco S, Yokoyama WM. In vivo developmental stages in murine natural killer cell maturation. Nat Immunol 2002; 3:523-8.
12. Freud AG, Yokohama A, Becknell B, Lee MT, Mao HC, Ferketich AK, Caligiuri MA. Evidence for discrete stages of human natural killer cell differentiation in vivo. J Exp Med 2006; 203:1033-43.
13. De Colvenaer V, Taveirne S, Delforche M et al. CD27-deficient mice show normal NK-cell differentiation but impaired function upon stimulation. Immunol Cell Biol 2011; 89:803-11.
14. - NK cells are associated with the progression of lung carcinoma. PLoS ONE 2013; 8:e61024.
15. Fu B, Wang F, Sun R, Ling B, Tian Z, Wei H. CD11b and CD27 reflect distinct population and functional specialization in human natural killer cells. Immunology 2011; 133:350-9.
16. Shi FD, Ljunggren HG, La Cava A, Van Kaer L. Organ-specific features of natural killer cells. Nat Rev Immunol 2011; 11:658-71.
17. Tian Z, Chen Y, Gao B. Natural killer cells in liver disease. Hepatology 2013; 57:1654-62.
18. Sun HY, Sun C, Tian ZG, Xiao WH. NK cells in immunotolerant organs. Cell Mol Immunol 2013; 10:202-12.
19. Peng H, Jiang X, Chen Y et al. Liver-resident NK cells confer adaptive immunity in skin-contact inflammation. J Clin Invest 2013; 123:1444-56.
20. Arck PC, Hecher K. Fetomaternal immune cross-talk and its consequences for maternal and offspring's health. Nat Med 2013; 19:548-56.
21. Man YG, Stojadinovic A, Mason J et al. Tumor-infiltrating immune cells promoting tumor invasion and metastasis: existing theories. J Cancer 2013; 4:84-95.
22. McKenna HJ, Stocking KL, Miller RE et al. Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells. Blood 2000; 95:3489-97.
23. Farag SS, Caligiuri MA. Human natural killer cell development and biology. Blood Rev 2006; 20:123-37.
24. + Nk progenitor. Blood 1994; 83:2594-601.
25. + hematopoietic progenitor cells. Blood 1996; 87:2632-40.
26. Freud AG, Caligiuri MA. Human natural killer cell development. Immunol Rev 2006; 214:56-72.
27. bright natural killer cells. Immunity 2005; 22:295-304.
28. bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity. Blood 2003; 101:3052-7.
29. Lynch L, O'Donoghue D, Dean J, O'Sullivan J, O'Farrelly C, Golden-Mason L. Detection and characterization of hemopoietic stem cells in the adult human small intestine. J Immunol 2006; 176:5199-204.
30. + immune precursors reside in human adult intestine and differentiate into natural killer cells. Gastroenterology 2007; 133:559-73.
31. Huntington ND, Vosshenrich CAJ, Di Santo JP. Developmental pathways that generate natural-killer-cell diversity in mice and humans. Nat Rev Immunol 2007; 7:703-14.
32. Bernardini G, Gismondi A, Santoni A. Chemokines and NK cells: regulators of development, trafficking and functions. Immunol Lett 2012; 145:39-46.
33. - human natural killer cells. Blood 2003; 102:1569-77.
34. Yu YR, Fong AM, Combadiere C, Gao JL, Murphy PM, Patel DD. Defective antitumor responses in CX3CR1-deficient mice. Int J Cancer 2007; 121:316-22.
35. Paust S, Gill HS, Wang BZ et al. Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses. Nat Immunol 2010; 11:1127-35.
36. + NK cells in immunopathogenesis of systemic lupus erythematosus. J Immunol 2011; 186:3421-31.
37. Sun C, Fu B, Gao Y, Liao X, Sun R, Tian Z, Wei H. TGF-β1 down-regulation of NKG2D/DAP10 and 2B4/SAP expression on human NK cells contributes to HBV persistence. PLoS Pathog 2012; 8:e1002594.
38. + T regulatory cells suppress NK cell-mediated immunotherapy of cancer. J Immunol 2006; 176:1582-7.
39. Pedroza-Pacheco I, Madrigal A, Saudemont A. Interaction between natural killer cells and regulatory T cells: perspectives for immunotherapy. Cell Mol Immunol 2013; 10:222-9.
40. Soderquest K, Powell N, Luci C et al. Monocytes control natural killer cell differentiation to effector phenotypes. Blood 2011; 117:4511-18.
41. Ganal SC, Sanos SL, Kallfass C et al. Priming of natural killer cells by nonmucosal mononuclear phagocytes requires instructive signals from commensal microbiota. Immunity 2012; 37:171-86.
42. Jaeger BN, Donadieu J, Cognet C et al. Neutrophil depletion impairs natural killer cell maturation, function, and homeostasis. J Exp Med 2012; 209:565-80.
43. Gascoyne DM, Long E, Veiga-Fernandes H et al. The basic leucine zipper transcription factor E4BP4 is essential for natural killer cell development. Nat Immunol 2009; 10:1118-24.
44. Colucci F, Samson SI, DeKoter RP, Lantz O, Singh H, Di Santo JP. Differential requirement for the transcription factor PU.1 in the generation of natural killer cells versus B and T cells. Blood 2001; 97:2625-32.
45. Ramirez K, Chandler KJ, Spaulding C, Zandi S, Sigvardsson M, Graves BJ, Kee BL. Gene deregulation and chronic activation in natural killer cells deficient in the transcription factor ETS1. Immunity 2012; 36:921-32.
46. Boggs SS, Trevisan M, Patrene K, Geogopoulos K. Lack of natural killer cell precursors in fetal liver of Ikaros knockout mutant mice. Nat Immun 1998; 16:137-45.
47. Boos MD, Yokota Y, Eberl G, Kee BL. Mature natural killer cell and lymphoid tissue-inducing cell development requires Id2-mediated suppression of E protein activity. J Exp Med 2007; 204:1119-30.
48. Gordon SM, Chaix J, Rupp LJ, Wu J, Madera S, Sun JC, Lindsten T, Reiner SL. The transcription factors t-bet and eomes control key checkpoints of natural killer cell maturation. Immunity 2012; 36:55-67.
49. Samson SI, Richard O, Tavian M et al. GATA-3 promotes maturation, IFN-γ production, and liver-specific homing of NK cells. Immunity 2003; 19:701-11.
50. Kallies A, Carotta S, Huntington ND, Bernard NJ, Tarlinton DM, Smyth MJ, Nutt SL. A role for Blimp1 in the transcriptional network controlling natural killer cell maturation. Blood 2011; 117:1869-79.
51. Walzer T, Dalod M, Robbins SH, Zitvogel L, Vivier E. Natural-killer cells and dendritic cells: "l'union fait la force". Blood 2005; 106:2252-8.
52. Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S. Functions of natural killer cells. Nat Immunol 2008; 9:503-10.
53. Ni F, Sun R, Fu B, Wang F, Guo C, Tian Z, Wei H. IGF-1 promotes the development and cytotoxic activity of human NK cells. Nat Commun 2013; 4:1479.
54. - NK cells with similarities to decidual NK cells. Proc Natl Acad Sci USA 2007; 104:3378-83.
55. bright NK cells. J Immunother 2010; 33:382-90.
56. + hematopoietic precursors are present in human decidua and differentiate into natural killer cells upon interaction with stromal cells. Proc Natl Acad Sci USA 2011; 108:2402-7.
57. Manaster I, Mizrahi S, Goldman-Wohl D et al. Endometrial NK cells are special immature cells that await pregnancy. J Immunol 2008; 181:1869-76.
58. Koopman LA, Kopcow HD, Rybalov B et al. Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential. J Exp Med 2003; 198:1201-12.
59. Male V, Hughes T, McClory S, Colucci F, Caligiuri MA, Moffett A. Immature NK cells, capable of producing IL-22, are present in human uterine mucosa. J Immunol 2010; 185:3913-18.
60. Ashkar AA, Di Santo JP, Croy BA. Interferon-γ contributes to initiation of uterine vascular modification, decidual integrity, and uterine natural killer cell maturation during normal murine pregnancy. J Exp Med 2000; 192:259-70.
61. Croy BA, He H, Esadeg S et al. Uterine natural killer cells: insights into their cellular and molecular biology from mouse modelling. Reproduction 2003; 126:149-60.
62. Zhang JH, Chen ZL, Smith GN, Croy BA. Natural killer cell-triggered vascular transformation: maternal care before birth? Cell Mol Immunol 2011; 8:1-11.
63. Hanna J, Goldman-Wohl D, Hamani Y et al. Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat Med 2006; 12:1065-74.
64. Sargent IL, Borzychowski AM, Redman CWG. NK cells and human pregnancy - an inflammatory view. Trends Immunol 2006; 27:399-404.
65. H17 cells at the human maternal-fetal interface. Proc Natl Acad Sci USA 2013; 110:E231-40.
66. + myelomonocytic cells results in induction of Tregs and immunosuppression. Proc Natl Acad Sci USA 2010; 107:11918-23.
67. Sharkey AM, Gardner L, Hiby S et al. Killer Ig-like receptor expression in uterine NK cells is biased toward recognition gestational age. J Immunol 2008; 181:39-46.
68. Xu W, Fazekas G, Hara H, Tabira T. Mechanism of natural killer (NK) cell regulatory role in experimental autoimmune encephalomyelitis. J Neuroimmunol 2005; 163:24-30.
69. Zhang BN, Yamamura T, Kondo T, Fujiwara M, Tabira T. Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells. J Exp Med 1997; 186:1677-87.
70. Matsumoto Y, Kohyama K, Aikawa Y, Shin T, Kawazoe Y, Suzuki Y, Tanuma N. Role of natural killer cells and TCR γδ T cells in acute autoimmune encephalomyelitis. Eur J Immunol 1998; 28:1681-8.
71. Hao J, Liu R, Piao W et al. Central nervous system (CNS)-resident natural killer cells suppress Th17 responses and CNS autoimmune pathology. J Exp Med 2010; 207:1907-21.
72. Rose JW, Watt HE, White AT, Carlson NG. Treatment of multiple sclerosis with an anti-interleukin-2 receptor monoclonal antibody. Ann Neurol 2004; 56:864-7.
73. Rose JW, Burns JB, Bjorklund J, Klein J, Watt HE, Carlson NG. Daclizumab phase II trial in relapsing and remitting multiple sclerosis - MRI and clinical results. Neurology 2007; 69:785-9.
74. Bielekova B, Howard T, Packer AN et al. Effect of anti-CD25 antibody daclizumab in the inhibition of inflammation and stabilization of disease progression in multiple sclerosis. Arch Neurol-Chicago 2009; 66:483-9.
75. bright natural killer cells mediate immunomodulatory effects of IL-2R α-targeted therapy (daclizumab) in multiple sclerosis. Proc Natl Acad Sci USA 2006; 103:5941-6.
76. Ballas ZK, Buchta CM, Rosean TR, Heusel JW, Shey MR. Role of NK cell subsets in organ-specific murine melanoma metastasis. PLoS ONE 2013; 8:e65599.
77. Li FL, Tian ZG. The liver works as a school to educate regulatory immune cells. Cell Mol Immunol 2013; 10:292-302.
78. negative phenotype. Rheumatology 2003; 42:870-8.
79. Micco L, Peppa D, Loggi E et al. Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-α therapy of chronic hepatitis B. J Hepatol 2013; 58:225-33.